Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,722 | 487 | 98.1% |
| Education | $170.84 | 5 | 1.9% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,475 | 78 | $0 (2024) |
| ABBVIE INC. | $702.19 | 41 | $0 (2024) |
| Amgen Inc. | $627.94 | 37 | $0 (2024) |
| Allergan, Inc. | $554.04 | 32 | $0 (2022) |
| PFIZER INC. | $546.96 | 33 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $516.58 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $481.38 | 30 | $0 (2024) |
| Coloplast Corp | $340.36 | 19 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $292.41 | 17 | $0 (2022) |
| Cook Medical LLC | $209.24 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,028 | 46 | PROCEPT BioRobotics Corporation ($169.50) |
| 2023 | $729.63 | 36 | ABBVIE INC. ($141.95) |
| 2022 | $891.71 | 49 | ABBVIE INC. ($118.27) |
| 2021 | $1,148 | 62 | Astellas Pharma US Inc ($227.74) |
| 2020 | $914.64 | 48 | Astellas Pharma US Inc ($207.45) |
| 2019 | $1,386 | 80 | Astellas Pharma US Inc ($345.78) |
| 2018 | $1,446 | 93 | Astellas Pharma US Inc ($238.32) |
| 2017 | $1,350 | 86 | Cook Incorporated ($169.71) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/06/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $15.78 | General |
| Category: Prostate cancer | ||||||
| 11/25/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $75.06 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: UROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Immunotherapy | ||||||
| 10/28/2024 | CIVCO Medical Instruments | — | Food and Beverage | Cash or cash equivalent | $22.81 | General |
| 10/16/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Oncology | ||||||
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: UROLOGY | ||||||
| 09/20/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Urology Gynecology | ||||||
| 09/10/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: UROLOGY | ||||||
| 08/28/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $94.44 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: UROLOGY | ||||||
| 08/01/2024 | Cook Medical LLC | COOK (Device) | Food and Beverage | Cash or cash equivalent | $32.09 | General |
| Category: Urology | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Oncology | ||||||
| 07/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: UROLOGY | ||||||
| 06/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: UROLOGY | ||||||
| 06/27/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $37.02 | General |
| Category: AMS 700_URO | ||||||
| 06/24/2024 | Sagent Pharmaceuticals | Glydo (Drug) | Food and Beverage | Cash or cash equivalent | $15.14 | General |
| Category: Topical local anesthetic | ||||||
| 06/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/30/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,552 | 6,503 | $603,671 | $181,800 |
| 2022 | 30 | 2,253 | 5,626 | $536,700 | $158,132 |
| 2021 | 29 | 2,248 | 5,069 | $531,391 | $154,880 |
| 2020 | 35 | 2,376 | 7,139 | $496,133 | $149,468 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 618 | 1,069 | $342,314 | $97,647 | 28.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 115 | $38,640 | $15,427 | 39.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 77 | 317 | $50,403 | $15,400 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 192 | 223 | $50,621 | $14,676 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $34,028 | $9,653 | 28.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 55 | 62 | $12,834 | $3,643 | 28.4% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 19 | 19 | $9,842 | $3,580 | 36.4% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 114 | 152 | $9,120 | $3,214 | 35.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 31 | 32 | $6,688 | $2,621 | 39.2% |
| 51705 | Simple change of bladder tube | Office | 2023 | 18 | 35 | $8,505 | $2,428 | 28.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 617 | 1,038 | $5,190 | $2,269 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $6,810 | $1,992 | 29.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 195 | 241 | $6,266 | $1,803 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 185 | 243 | $1,458 | $1,423 | 97.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 16 | 30 | $4,680 | $1,404 | 30.0% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $4,662 | $1,359 | 29.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 41 | $3,321 | $1,051 | 31.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 60 | $2,100 | $621.04 | 29.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 15 | 15 | $975.00 | $357.70 | 36.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 13 | 13 | $819.00 | $294.24 | 35.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 25 | 2,500 | $2,500 | $271.90 | 10.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 59 | $354.00 | $201.19 | 56.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 51 | 55 | $385.00 | $171.05 | 44.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Facility | 2023 | 22 | 23 | $598.00 | $165.60 | 27.7% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2023 | 20 | 21 | $462.00 | $65.55 | 14.2% |
About Dr. James Renehan, MD
Dr. James Renehan, MD is a Urology healthcare provider based in Tallahassee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386607117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Renehan, MD has received a total of $8,893 in payments from pharmaceutical and medical device companies, with $1,028 received in 2024. These payments were reported across 500 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($8,722).
As a Medicare-enrolled provider, Renehan has provided services to 9,429 Medicare beneficiaries, totaling 24,337 services with total Medicare billing of $644,280. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Tallahassee, FL
- Active Since 04/11/2006
- Last Updated 03/15/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1386607117
Products in Payments
- XTANDI (Drug) $897.76
- BOTOX (Biological) $704.17
- MYRBETRIQ (Drug) $544.52
- Prolia (Biological) $484.26
- XIAFLEX (Biological) $469.22
- ELIGARD (Drug) $319.67
- Myrbetriq (Drug) $276.66
- GEMTESA (Drug) $210.53
- ERLEADA (Drug) $206.58
- BOTOX THERAPEUTIC (Biological) $201.82
- AQUABEAM SYSTEM (Device) $169.50
- Noctiva (Drug) $167.99
- PROVENGE (Drug) $166.50
- Androgel (Drug) $162.89
- ZYTIGA (Drug) $159.39
- INTERSTIM (Device) $153.20
- Axonics r-SNM System (Device) $143.41
- XYOSTED (Drug) $135.18
- XGEVA (Biological) $130.55
- Titan (Device) $129.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Tallahassee
Dr. Scott Sellinger, Md, MD
Urology — Payments: $2.1M
Dr. Jean-Paul Tran, Md, MD
Urology — Payments: $23,918
Dr. Robert Bradford, Md, MD
Urology — Payments: $17,195
Dr. Joseph Camps, Md, MD
Urology — Payments: $9,784
Jamey Sarvis
Urology — Payments: $9,765
Dr. Christopher Murphy, D.o, D.O
Urology — Payments: $9,130